Publication Name	World Journal of Cardiology
Manuscript ID	75083
Country	Thailand

Received	2022-01-15 15:23
Peer-Review Started	2022-01-15 15:24
To Make the First Decision
Return for Revision	2022-03-16 02:33
Revised	2022-03-27 06:08
Second Decision	2022-05-16 03:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-05-17 04:52
Articles in Press	2022-05-17 04:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-06-02 03:55
Publish the Manuscript Online	2022-06-21 01:59

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	COVID-19 vaccination and cardiac dysfunction
Manuscript Source	Invited Manuscript
All Author List	Wattana Leowattana and Tawithep Leowattana
Funding Agency and Grant Number
Corresponding Author	Wattana Leowattana, MD, MSc, PhD, Professor, Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajavithi road, Rajatawee, Bangkok 10400, Thailand. wattana.leo@mahidol.ac.th
Key Words	Cardiac dysfunction; Myocarditis; Pericarditis; COVID-19; mRNA vaccine; Electrocardiography; Echocardiography; SARS-CoV-2
Core Tip	A possible hypersensitivity myocarditis with a consistent relationship to administering an mRNA coronavirus disease 2019 (COVID-19) vaccination was reported. While the actual prevalence of this adverse event is unclear at this time, the clinical manifestation and pathological findings point to a link with an inflammatory reaction to a COVID-19 immunization. However, acute myocarditis following mRNA COVID-19 vaccination was very low and mostly self-limited. Moreover, the high efficacy of mRNA COVID-19 vaccines in preventing further pandemic conditions, reducing disease severity, and the occurrence of a very low incidence of myocarditis following immunization should be a strength of an mRNA COVID-19 vaccine for public trust.
Publish Date	2022-06-21 01:59
Citation	Leowattana W, Leowattana T. COVID-19 vaccination and cardiac dysfunction. World J Cardiol 2022; 14(6): 343-354
URL	https://www.wjgnet.com/1949-8462/full/v14/i6/343.htm
DOI	https://dx.doi.org/10.4330/wjc.v14.i6.343

Full Article (PDF)	WJC-14-343.pdf
Full Article (Word)	WJC-14-343.docx
Manuscript File	75083_Auto_Edited-LS.docx
Answering Reviewers	75083-Answering reviewers.pdf
Audio Core Tip	75083-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	75083-Conflict-of-interest statement.pdf
Copyright License Agreement	75083-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	75083-Language certificate.pdf
Peer-review Report	75083-Peer-review(s).pdf
Scientific Misconduct Check	75083-Bing-Fan JR-2.png
Scientific Editor Work List	75083-Scientific editor work list.pdf